For the past two years federal regulators have issued subpoenas and scrutinized relationships between drug companies and the charities, which are supposed to operate independently from industry donors.
DebugScreen: mobile
{
"author": {
"name": "Robert Langreth Benjamin Elgin",
"webUrl": "/author/profile/robert-langreth-benjamin-elgin/",
"description": "",
"imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
"estimate": 1,
"social": [],
"articles": [
{
"uri": "/2017/12/27/drug-companies-relationships-with-patient-assistan/",
"title": "Drug companies' relationships with patient-assistance charities under scrutiny",
"byline": " Robert Langreth, Benjamin Elgin ",
"kicker": "",
"prettyDate": "December 27, 2017",
"timeToRead": "6 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/robert-langreth-benjamin-elgin/",
"name": "Robert Langreth, Benjamin Elgin"
}
],
"kickerNode": [],
"summary": "For the past two years federal regulators have issued subpoenas and scrutinized relationships between drug companies and the charities, which are supposed to operate independently from industry donors.",
"body": null
}
]
}
}